Ashfaq A. Parkar

762 total citations
12 papers, 612 citations indexed

About

Ashfaq A. Parkar is a scholar working on Molecular Biology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, Ashfaq A. Parkar has authored 12 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cell Biology and 3 papers in Immunology and Allergy. Recurrent topics in Ashfaq A. Parkar's work include Sphingolipid Metabolism and Signaling (3 papers), Cell Adhesion Molecules Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Ashfaq A. Parkar is often cited by papers focused on Sphingolipid Metabolism and Signaling (3 papers), Cell Adhesion Molecules Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Ashfaq A. Parkar collaborates with scholars based in United States, France and United Kingdom. Ashfaq A. Parkar's co-authors include Anthony J. Day, Iain D. Campbell, Craig J. Morton, Hideki Hatanaka, Daisuke Kohda, Jan D. Kahmann, Michael T. Bayliss, Sarah Howat, Bryan C. Fuchs and Anthony J. Sinskey and has published in prestigious journals such as Cell, PLoS ONE and FEBS Letters.

In The Last Decade

Ashfaq A. Parkar

12 papers receiving 602 citations

Peers

Ashfaq A. Parkar
S. Park-Snyder United States
Ashfaq A. Parkar
Citations per year, relative to Ashfaq A. Parkar Ashfaq A. Parkar (= 1×) peers S. Park-Snyder

Countries citing papers authored by Ashfaq A. Parkar

Since Specialization
Citations

This map shows the geographic impact of Ashfaq A. Parkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashfaq A. Parkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashfaq A. Parkar more than expected).

Fields of papers citing papers by Ashfaq A. Parkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashfaq A. Parkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashfaq A. Parkar. The network helps show where Ashfaq A. Parkar may publish in the future.

Co-authorship network of co-authors of Ashfaq A. Parkar

This figure shows the co-authorship network connecting the top 25 collaborators of Ashfaq A. Parkar. A scholar is included among the top collaborators of Ashfaq A. Parkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashfaq A. Parkar. Ashfaq A. Parkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Poirier, Bruno, Anne‐Marie Lefebvre, Alain Roccon, et al.. (2022). A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome. PLoS ONE. 17(1). e0257929–e0257929. 6 indexed citations
2.
Beauverger, Philippe, et al.. (2020). A label‐free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P1 agonists. FEBS Open Bio. 10(10). 2010–2020. 6 indexed citations
4.
Poirier, Bruno, Dieter Kadereit, Mathias Schäfer, et al.. (2020). A G protein–biased S1P 1 agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers. Science Signaling. 13(634). 28 indexed citations
5.
Fuchs, Bryan C., Yan Yang, Lan Wei, et al.. (2013). Molecular MRI of collagen to diagnose and stage liver fibrosis. Journal of Hepatology. 59(5). 992–998. 118 indexed citations
6.
McLean, Larry R., Ying Zhang, Xiping Bi, et al.. (2012). X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 22(9). 3296–3300. 21 indexed citations
7.
Mu, Lan, Ali Ardati, Bin Cao, et al.. (2010). Understanding DP receptor antagonism using a CoMSIA approach. Bioorganic & Medicinal Chemistry Letters. 21(1). 66–75. 2 indexed citations
8.
Lindauer, Klaus, Ashfaq A. Parkar, Ian Hayes, et al.. (2001). Analysis of cellular adhesion by microarray expression profiling. Journal of Immunological Methods. 250(1-2). 15–28. 9 indexed citations
9.
Parkar, Ashfaq A., et al.. (2000). Large-Scale Expression, Refolding, and Purification of the Catalytic Domain of Human Macrophage Metalloelastase (MMP-12) in Escherichia coli. Protein Expression and Purification. 20(2). 152–161. 28 indexed citations
10.
Parkar, Ashfaq A., Jan D. Kahmann, Sarah Howat, Michael T. Bayliss, & Anthony J. Day. (1998). TSG‐6 interacts with hyaluronan and aggrecan in a pH‐dependent manner via a common functional element: implications for its regulation in inflamed cartilage. FEBS Letters. 428(3). 171–176. 61 indexed citations
11.
Parkar, Ashfaq A. & Anthony J. Day. (1997). Overlapping sites on the Link module of human TSG‐6 mediate binding to hyaluronan and chondroitin‐4‐sulphate. FEBS Letters. 410(2-3). 413–417. 69 indexed citations
12.
Kohda, Daisuke, Craig J. Morton, Ashfaq A. Parkar, et al.. (1996). Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration. Cell. 86(5). 767–775. 255 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026